SCHEMBL20060908

SCHEMBL20060908

CNC(=O)c1ccc(OCC[C@@H]2C[C@@H]2C2CCN(C(=O)[C@H](c3ccccc3)C(F)(F)F)CC2)cc1Cl

nearest known ligand 0.44

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ GPR119 Q8TDV5 13/20 0.44
▸ KCNH2 Q12809 11/20 0.44
▸ F10 P00742 3/20 0.36
▸ PTGIR P43119 1/20 0.35
▸ HTR1A P08908 2/20 0.34
▸ DRD2 P14416 2/20 0.34
▸ HTR2A P28223 2/20 0.34
▸ ITGB3 P05106 1/20 0.34
▸ ITGA2B P08514 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20060917 0.92 GPR119 (0.46) GPR119KCNH2HTR1ADRD2HTR2A
SCHEMBL22311301 0.85 NR1H2 (0.49) GPR119KCNH2PTGIRHTR1ADRD2
SCHEMBL22311299 0.85 NR1H2 (0.49) GPR119KCNH2PTGIRHTR1ADRD2
SCHEMBL25549350 0.85 NR1H2 (0.49) GPR119KCNH2PTGIRHTR1ADRD2
SCHEMBL25547752 0.83 GPR119 (0.44) GPR119KCNH2PTGIRHTR1ADRD2
SCHEMBL20060926 0.82 NR1H2 (0.39) GPR119KCNH2
SCHEMBL22311049 0.80 GPR119 (0.43) GPR119KCNH2HTR1ADRD2HTR2A
SCHEMBL22311060 0.80 GPR119 (0.46) GPR119KCNH2HTR1ADRD2HTR2A
SCHEMBL22311061 0.80 GPR119 (0.46) GPR119KCNH2HTR1ADRD2HTR2A
SCHEMBL22310515 0.79 GPR119 (0.42) GPR119KCNH2HTR1ADRD2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018068295-A1 ARYL AND HETEROARYL ETHER DERIVATIVES AS LIVER X RECEPTOR β AGONISTS, COMPOSITIONS, AND THEIR USE MERCK SHARP & DOHME CORP. (US) 2018-04-19 — — WO disclosed
WO-2018071317-A1 ARYL AND HETEROARYL ETHER DERIVATIVES AS LIVER X RECEPTOR BETA AGONISTS MERCK SHARP & DOHME CORP. (US) 2018-04-19 — — WO disclosed
Send feedback